Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1656911

registered interest
date	01/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to reduce respiratory health inequalities.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	196576
answer	answer is ministerial correction date of answer 07/09/2023 answer text <p>The NHS Long Term Plan made a commitment to tackling health inequalities and earlier intervention to detect and treat respiratory disease. NHS England has set out Core20PLUS5, a national approach to reduce healthcare inequalities at both national and system level. The approach defines a target population (the ‘Core20PLUS’) and identifies ‘5’ focus clinical areas requiring accelerated improvement.</p><p>The approach will include a focus on Chronic Obstructive Pulmonary Disease driving up uptake of COVID-19, flu and pneumonia vaccines to reduce exacerbations of the disease and to reduce emergency hospital admissions due to those exacerbations, as well as smoking cessation given the strong social gradient in smoking rates that contributes to inequalities in respiratory disease and other major causes of death.</p> answering member constituency Colchester answering member printed Will Quince question first answered 07/09/2023 15:15:02 answering member 4423 label Biography information for Will Quince
tabling member	4488 label Biography information for Martyn Day

1642100

registered interest
date	06/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help reduce lung and respiratory-related deaths in the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	187976
answer	answer is ministerial correction date of answer 14/06/2023 answer text <p>NHS England has established a national respiratory programme to develop a clear approach, in partnership with its partners, to improve outcomes for people with respiratory disease and meet the Long Term Plan ambitions. In addition, the Major Conditions Strategy will cover treatment and prevention for chronic respiratory diseases and seeking input, through our Call for Evidence, from stakeholders, citizens and the NHS to identify actions that will have the most impact.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 14/06/2023 16:30:09 answering member 4527 label Biography information for Helen Whately
tabling member	4131 label Biography information for Jim Shannon

1608333

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he is taking steps to ensure that (a) asthma, (b) chronic obstructive pulmonary disease and (c) other respiratory health diseases are priorities of the forthcoming Major Conditions and Disease Strategy.
tabling member constituency	Rutherglen and Hamilton West
tabling member printed	Margaret Ferrier
uin	175614
answer	answer is ministerial correction date of answer 03/04/2023 answer text <p>Work on the Major Conditions Strategy is ongoing and we are committed to ensuring that the Strategy’s approach is rooted in the best understanding of the evidence to tackle the major conditions which contribute to the burden of disease in England, including respiratory conditions. This includes seeking the views of and working closely with stakeholders, citizens and the National Health Service.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 175616 question first answered 03/04/2023 10:57:00 answering member 4527 label Biography information for Helen Whately
tabling member	4386 label Biography information for Margaret Ferrier

1608335

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps (a) his Department and (b) NHS England have taken to tackle increases in respiratory health conditions in the context of recent changes to GP contracts.
tabling member constituency	Rutherglen and Hamilton West
tabling member printed	Margaret Ferrier
uin	175615
answer	answer is ministerial correction date of answer 04/04/2023 answer text <p>General Practices (GPs) are required to provide services, termed ‘essential services’, to meet the reasonable needs of their registered and temporary patients. This includes providing consultations, referrals and ongoing treatment and care as necessary and appropriate.</p><p>Some GP practices may opt into providing additional services over and above this. The Quality and Outcomes Framework (QOF) is a voluntary reward and incentive scheme to help improve the quality of care across GPs. This incentivises practices to undertake specific activities in order to improve prevention and long-term condition management, including tackling respiratory health conditions. In the 2023/24 GP contract, nine QOF indicators (16%) will target tackling respiratory health conditions.</p><p>Vaccination against COVID-19 and flu can also support a reduction in cases of respiratory virus during the winter, both amongst the general public and the healthcare workforce. Over 17.4 million doses of an autumn COVID-19 booster were delivered in England over winter 2022/23 and as of 28 February, more than 21.1 million people in England have had their flu jabs.</p><p>The vaccine programmes provide necessary protection to those at higher risk of severe illness and are keeping more people out of hospital. The Government encourages all of those who are eligible for vaccinations to come forward.</p><p>The Department continues to work with tripartite partners to deliver improvements to vaccinations, including acquiring data to allow for timely and targeted action, and to identify and provide advice on reducing disparities in vaccination coverage.</p><p>The tripartite is committed to improving childhood and adult immunisation programmes, driving maximum uptake, and working hard towards re-gaining the United Kingdom’s measles elimination status, and sustaining our rubella and polio status.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 04/04/2023 13:37:26 answering member 4679 label Biography information for Neil O'Brien
tabling member	4386 label Biography information for Margaret Ferrier

1467593

registered interest
date	06/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people living with lung disease as of 6 June 2022.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13131
answer	answer is ministerial correction date of answer 20/06/2022 answer text <p>No specific estimate has been made as this information is not collected in the format requested. However, data from the Quality and Outcomes Framework in 2020/21 shows the prevalence of asthma was 6.38% and 1.38% for chronic obstructive pulmonary disease.</p> answering member constituency Chichester answering member printed Gillian Keegan question first answered 20/06/2022 14:10:06 answering member 4680 label Biography information for Gillian Keegan
tabling member	4131 label Biography information for Jim Shannon

1416317

registered interest
date	25/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people have been diagnosed with pulmonary fibrosis in each year from 2010-11 to 2020-21 in (a) England, (b) Wales, (c) Scotland and (d) Northern Ireland.
tabling member constituency	Luton South
tabling member printed	Rachel Hopkins
uin	111776
answer	answer is ministerial correction date of answer 08/02/2022 answer text <p>The information requested for the number of diagnoses and deaths in England due to pulmonary fibrosis is not held. The information requested for Wales, Scotland and Northern Ireland is not collected as this is a devolved matter.</p><p>The National Institute of Health and Care Excellence recently undertook a single technology appraisal of nintedanib, an anti-fibrotic drug for use in patients with many different types of progressive lung fibrosis. The drug is being commissioned by NHS England and NHS Improvement and will be available from 17 February 2022. It is expected it will allow treatment for fibrosis to be administered to a wider group of patients and prolong the lives of many. NHS England and NHS Improvement have amended the dashboard overseeing the performance of specialist interstitial lung disease centres in England. This is intended to deliver improved care for patients with pulmonary fibrosis, focussing on patient outcomes, involvement in research trials and reducing waits in services. The National Institute for Health Research (NIHR) awarded £696,932 for research into pulmonary fibrosis in 2020/21. Currently, the NIHR supports 122 studies into pulmonary fibrosis.</p> answering member constituency Chichester answering member printed Gillian Keegan grouped question UIN 111777 111778 111779 question first answered 08/02/2022 15:38:52 answering member 4680 label Biography information for Gillian Keegan
tabling member	4873 label Biography information for Rachel Hopkins

1416318

registered interest
date	25/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) treatment and (b) support for people living with pulmonary fibrosis.
tabling member constituency	Luton South
tabling member printed	Rachel Hopkins
uin	111777
answer	answer is ministerial correction date of answer 08/02/2022 answer text <p>The information requested for the number of diagnoses and deaths in England due to pulmonary fibrosis is not held. The information requested for Wales, Scotland and Northern Ireland is not collected as this is a devolved matter.</p><p>The National Institute of Health and Care Excellence recently undertook a single technology appraisal of nintedanib, an anti-fibrotic drug for use in patients with many different types of progressive lung fibrosis. The drug is being commissioned by NHS England and NHS Improvement and will be available from 17 February 2022. It is expected it will allow treatment for fibrosis to be administered to a wider group of patients and prolong the lives of many. NHS England and NHS Improvement have amended the dashboard overseeing the performance of specialist interstitial lung disease centres in England. This is intended to deliver improved care for patients with pulmonary fibrosis, focussing on patient outcomes, involvement in research trials and reducing waits in services. The National Institute for Health Research (NIHR) awarded £696,932 for research into pulmonary fibrosis in 2020/21. Currently, the NIHR supports 122 studies into pulmonary fibrosis.</p> answering member constituency Chichester answering member printed Gillian Keegan grouped question UIN 111776 111778 111779 question first answered 08/02/2022 15:38:52 answering member 4680 label Biography information for Gillian Keegan
tabling member	4873 label Biography information for Rachel Hopkins

1330035

registered interest
date	07/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what is the median time to a first appointment with a specialist respiratory consultant when a serious lung condition is suspected, for each hospital Trust in England, for each of the last five years.
tabling member constituency	West Ham
tabling member printed	Ms Lyn Brown
uin	11514
answer	answer is ministerial correction date of answer 16/06/2021 answer text <p>The data is not available in the format requested.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 16/06/2021 12:46:13 answering member 4362 label Biography information for Edward Argar
tabling member	1583 label Biography information for Ms Lyn Brown

1330036

registered interest
date	07/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what is the median time to a first diagnostic a) x-ray, b) CT scan, and c) spirometry test, where a serious lung condition is suspected, for each hospital Trust in England, for each of the last five years.
tabling member constituency	West Ham
tabling member printed	Ms Lyn Brown
uin	11515
answer	answer is ministerial correction date of answer 16/06/2021 answer text <p>The data is not available in the format requested.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 16/06/2021 12:47:44 answering member 4362 label Biography information for Edward Argar
tabling member	1583 label Biography information for Ms Lyn Brown

1330037

registered interest
date	07/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what is the median time to a diagnosis of Pulmonary Fibrosis, from first presentation to a GP with respiratory symptoms, for each hospital Trust in England, for each of the last five years.
tabling member constituency	West Ham
tabling member printed	Ms Lyn Brown
uin	11516
answer	answer is ministerial correction date of answer 21/06/2021 answer text <p>The information is not collected in the format requested.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 21/06/2021 10:36:13 answering member 4380 label Biography information for Jo Churchill
tabling member	1583 label Biography information for Ms Lyn Brown